Matches in SemOpenAlex for { <https://semopenalex.org/work/W3195202382> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W3195202382 endingPage "S104" @default.
- W3195202382 startingPage "S104" @default.
- W3195202382 abstract "Objectives: The National Cancer Institute (NCI) Community Oncology Research Program (NCORP) was developed as a platform to study cancer care delivery at 23 community sites and 14 minority/underserved sites, encompassing 943 care delivery locations nationwide. We describe the capacity of the NCORP network to conduct cancer care delivery research for gynecologic cancers. We also characterize community practices where patients are treated for gynecologic cancers without an affiliated gynecologic oncologist, as these patients may be at higher risk for outcomes disparities. Methods: The 2017 Landscape Capacity Assessment (LCA) was designed by the NCI Division of Cancer Prevention and administered to 943 NCORP locations. This survey included elements related to clinical setting (e.g., size, location, characteristics of patients), staffing (e.g., number/types of care providers), and cancer care practices (e.g., genetic testing, patient navigation). Primary populations of interest were practices identified as providing gynecologic cancer services, and the subgroup of practices providing gynecologic cancer services without an affiliated gynecologic oncologist. χ2 tests were used to test for differences in categorical variables. Results: A total of 504/943 locations (54%), representing 227 practices completed the LCA; 17 practices solely providing pediatric care were excluded. A total of 46% of responding practices serve >1000 patients per year, 23% report at least 30% of new patients represent minority populations. 41% and 11% of practices report >10% of patients are insured through Medicaid, or are uninsured, respectively. 36% of practices are independently owned while 54% are owned by a larger health system. 22% of practices are embedded in Critical Access hospitals. 29% participate in the Oncology Care Model through the Centers for Medicare and Medicaid Services. 84% record patient data in an EHR. 30% of sites utilize telemedicine for cancer care and 51% of these practices can adapt telemedicine for research purposes. 93% of practices provide survivorship care. 129 groups (56%) reported GYN cancer services; 48% of all practices have an affiliated gynecologic oncologist (median 0; range 1-48). Practices evaluating >1000 patients annually were significantly more likely to offer GYN cancer services. No association was seen between availability of GYN cancer services and insurance mix, proportion of minority patients, use of telemedicine, or availability of community outreach staff. Of practices providing GYN cancer services, practices without an affiliated gynecologic oncologist were less likely to evaluate >1000 new patients annually (35% vs 76%; p<0.001), to have a genetic counselor on site (83% vs 49%, p<0.001), and to have support services available (e.g., social workers, pharmacists, dieticians, psychologists). No significant difference was seen in insurance mix, proportion of minority patients, use of EHR or telemedicine, or availability of community outreach staff between practices with and without an affiliated gynecologic oncologist (Table 1). Conclusions: NCORP offers a unique opportunity to study cancer care delivery in community settings, including in underserved minority populations. This platform should be considered for the study of interventional trials aimed at ensuring that patients receive high-quality gynecologic cancer care, especially in the high-risk population of patients who are treated in practices without an affiliated gynecologic oncologist. The National Cancer Institute (NCI) Community Oncology Research Program (NCORP) was developed as a platform to study cancer care delivery at 23 community sites and 14 minority/underserved sites, encompassing 943 care delivery locations nationwide. We describe the capacity of the NCORP network to conduct cancer care delivery research for gynecologic cancers. We also characterize community practices where patients are treated for gynecologic cancers without an affiliated gynecologic oncologist, as these patients may be at higher risk for outcomes disparities. The 2017 Landscape Capacity Assessment (LCA) was designed by the NCI Division of Cancer Prevention and administered to 943 NCORP locations. This survey included elements related to clinical setting (e.g., size, location, characteristics of patients), staffing (e.g., number/types of care providers), and cancer care practices (e.g., genetic testing, patient navigation). Primary populations of interest were practices identified as providing gynecologic cancer services, and the subgroup of practices providing gynecologic cancer services without an affiliated gynecologic oncologist. χ2 tests were used to test for differences in categorical variables. A total of 504/943 locations (54%), representing 227 practices completed the LCA; 17 practices solely providing pediatric care were excluded. A total of 46% of responding practices serve >1000 patients per year, 23% report at least 30% of new patients represent minority populations. 41% and 11% of practices report >10% of patients are insured through Medicaid, or are uninsured, respectively. 36% of practices are independently owned while 54% are owned by a larger health system. 22% of practices are embedded in Critical Access hospitals. 29% participate in the Oncology Care Model through the Centers for Medicare and Medicaid Services. 84% record patient data in an EHR. 30% of sites utilize telemedicine for cancer care and 51% of these practices can adapt telemedicine for research purposes. 93% of practices provide survivorship care. 129 groups (56%) reported GYN cancer services; 48% of all practices have an affiliated gynecologic oncologist (median 0; range 1-48). Practices evaluating >1000 patients annually were significantly more likely to offer GYN cancer services. No association was seen between availability of GYN cancer services and insurance mix, proportion of minority patients, use of telemedicine, or availability of community outreach staff. Of practices providing GYN cancer services, practices without an affiliated gynecologic oncologist were less likely to evaluate >1000 new patients annually (35% vs 76%; p<0.001), to have a genetic counselor on site (83% vs 49%, p<0.001), and to have support services available (e.g., social workers, pharmacists, dieticians, psychologists). No significant difference was seen in insurance mix, proportion of minority patients, use of EHR or telemedicine, or availability of community outreach staff between practices with and without an affiliated gynecologic oncologist (Table 1). NCORP offers a unique opportunity to study cancer care delivery in community settings, including in underserved minority populations. This platform should be considered for the study of interventional trials aimed at ensuring that patients receive high-quality gynecologic cancer care, especially in the high-risk population of patients who are treated in practices without an affiliated gynecologic oncologist." @default.
- W3195202382 created "2021-08-30" @default.
- W3195202382 creator A5023297494 @default.
- W3195202382 creator A5034100328 @default.
- W3195202382 creator A5044829571 @default.
- W3195202382 creator A5084235817 @default.
- W3195202382 date "2021-08-01" @default.
- W3195202382 modified "2023-10-16" @default.
- W3195202382 title "Capacity for cancer care delivery research in gynecologic oncology within the National Cancer Institute Community Oncology Research Program (NCORP)" @default.
- W3195202382 doi "https://doi.org/10.1016/s0090-8258(21)00840-4" @default.
- W3195202382 hasPublicationYear "2021" @default.
- W3195202382 type Work @default.
- W3195202382 sameAs 3195202382 @default.
- W3195202382 citedByCount "0" @default.
- W3195202382 crossrefType "journal-article" @default.
- W3195202382 hasAuthorship W3195202382A5023297494 @default.
- W3195202382 hasAuthorship W3195202382A5034100328 @default.
- W3195202382 hasAuthorship W3195202382A5044829571 @default.
- W3195202382 hasAuthorship W3195202382A5084235817 @default.
- W3195202382 hasConcept C121608353 @default.
- W3195202382 hasConcept C126322002 @default.
- W3195202382 hasConcept C143998085 @default.
- W3195202382 hasConcept C159110408 @default.
- W3195202382 hasConcept C160735492 @default.
- W3195202382 hasConcept C162324750 @default.
- W3195202382 hasConcept C184356942 @default.
- W3195202382 hasConcept C187736073 @default.
- W3195202382 hasConcept C2776534028 @default.
- W3195202382 hasConcept C2777512617 @default.
- W3195202382 hasConcept C2780427987 @default.
- W3195202382 hasConcept C2780435969 @default.
- W3195202382 hasConcept C2994372414 @default.
- W3195202382 hasConcept C50522688 @default.
- W3195202382 hasConcept C512399662 @default.
- W3195202382 hasConcept C71924100 @default.
- W3195202382 hasConceptScore W3195202382C121608353 @default.
- W3195202382 hasConceptScore W3195202382C126322002 @default.
- W3195202382 hasConceptScore W3195202382C143998085 @default.
- W3195202382 hasConceptScore W3195202382C159110408 @default.
- W3195202382 hasConceptScore W3195202382C160735492 @default.
- W3195202382 hasConceptScore W3195202382C162324750 @default.
- W3195202382 hasConceptScore W3195202382C184356942 @default.
- W3195202382 hasConceptScore W3195202382C187736073 @default.
- W3195202382 hasConceptScore W3195202382C2776534028 @default.
- W3195202382 hasConceptScore W3195202382C2777512617 @default.
- W3195202382 hasConceptScore W3195202382C2780427987 @default.
- W3195202382 hasConceptScore W3195202382C2780435969 @default.
- W3195202382 hasConceptScore W3195202382C2994372414 @default.
- W3195202382 hasConceptScore W3195202382C50522688 @default.
- W3195202382 hasConceptScore W3195202382C512399662 @default.
- W3195202382 hasConceptScore W3195202382C71924100 @default.
- W3195202382 hasLocation W31952023821 @default.
- W3195202382 hasOpenAccess W3195202382 @default.
- W3195202382 hasPrimaryLocation W31952023821 @default.
- W3195202382 hasRelatedWork W1979105414 @default.
- W3195202382 hasRelatedWork W1979332102 @default.
- W3195202382 hasRelatedWork W2095552983 @default.
- W3195202382 hasRelatedWork W2099838903 @default.
- W3195202382 hasRelatedWork W2115798260 @default.
- W3195202382 hasRelatedWork W3043846144 @default.
- W3195202382 hasRelatedWork W3131135199 @default.
- W3195202382 hasRelatedWork W3150366960 @default.
- W3195202382 hasRelatedWork W4244295897 @default.
- W3195202382 hasRelatedWork W4321165174 @default.
- W3195202382 hasVolume "162" @default.
- W3195202382 isParatext "false" @default.
- W3195202382 isRetracted "false" @default.
- W3195202382 magId "3195202382" @default.
- W3195202382 workType "article" @default.